Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Many HIV infected patients admitted to the intensive care area (ICA) have never taken
anti-HIV drugs. The purpose of this study is to learn whether starting anti-HIV drugs while
patients are in an ICA will help them to survive and get better faster. This study will also
evaluate patients who, though not in an ICA, have been admitted to the hospital for serious
illnesses or infections.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Efavirenz Lamivudine Lamivudine, zidovudine drug combination Nelfinavir Zidovudine